Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: A Children's Oncology Group Study

Blood

Volumn 119, Issue 15, 2012, Pages 3512-3522

  Chen, I Ming ^a,b   Harvey, Richard C ^a,b   Mullighan, Charles G ^c   Gastier Foster, Julie ^b,d,e   Wharton, Walker ^a   Kang, Huining ^a   Borowitz, Michael J ^b,f   Camitta, Bruce M ^b,g   Carroll, Andrew J ^b,h   Devidas, Meenakshi ^b,i   Pullen, D Jeanette ^b,j   Payne Turner, Debbie ^c   Tasian, Sarah K ^k   Reshmi, Shalini ^b,d,e   Cottrell, Catherine E ^d   Reaman, Gregory H ^b,l   Bowman, W Paul ^b,m   Carroll, William L ^b,n   Loh, Mignon L ^b,o   Winick, Naomi J ^b,p   Hunger, Stephen P ^b,q   Willman, Cheryl L ^a,b   more..

^a UNIVERSITY OF NEW MEXICO   (United States)

^b CHILDREN S ONCOLOGY GROUP   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

^e THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f DEPARTMENT OF PATHOLOGY   (United States)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁱ UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^k CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^l CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^m Pediatric Cardiothoracic Surgery   (United States)

ⁿ NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^q Children's Hospital Colorado   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CRLF2 PROTEIN; IKZF1 PROTEIN; JANUS KINASE; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILD; CLINICAL TRIAL; FEMALE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE REARRANGEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MODEL; OUTCOME MODELING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; SCHOOL CHILD;

EID: 84859820034     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-11-394221     Document Type: Article

References (25)

1. Russell LJ, Capasso M, Vater I, et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood. 2009;114(13):2688-2698.
2. Mullighan CG, Collins-Underwood JR, Phillips LA, et al. Rearrangement of CRLF2 in B-progenitor-and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet. 2009;41(11):1243- 1246.
3. Cario G, Zimmermann M, Romey R, et al. Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol. Blood. 2010;115(26):5393-5397.
4. Ensor HM, Schwab C, Russell LJ, et al. Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial. Blood. 2011;117(7):2129-2136.
5. Harvey RC, Mullighan CG, Chen IM, et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/ Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood. 2010;115(26):5312-5321.
6. Yoda A, Yoda Y, Chiaretti S, et al. Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2010;107(1):252-257.
7. Dyer MJ, Akasaka T, Capasso M, et al. Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers? Blood. 2010;115(8):1490-1499.
8. Hertzberg L, Vendramini E, Ganmore I, et al. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood. 2010;115(5):1006-1017.
9. Chapiro E, Russell L, Lainey E, et al. Activating mutation in the TSLPR gene in B-cell precussor lymphoblastic leukemia. Leukemia. 2010;24(3): 642-645.
10. Shochat C, Tal N, Bandapalli OR, et al. Gain-of-function mutations in interleukin-7 receptor-alpha (IL7R) in childhood acute lymphoblastic leukemias. J Exp Med. 2011;208(5):901-908.
11. Zhang J, Ding L, Holmfeldt L, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481(7380)157-163.
12. Winick N, Martin PL, Devidas M, et al. Delayed intensification (DI) enhances event-free survival (EFS) of children with B-precursor acute lymphoblastic leukemia (ALL) who received intensification therapy with six courses of intravenous methotrexate (MTX): POG 9904/9905 [abstract]. A Childrens Oncology Group Study (COG). Blood (ASH Annual Meeting Abstracts). 2007;110(11): 583.
13. Bowman WP, Larsen EL, Devidas M, et al. Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906. Pediatr Blood Cancer. 2011;57(4):569-577.
14. Shuster JJ, Camitta BM, Pullen J, et al. Identification of newly diagnosed children with acute lymphocytic leukemia at high risk for relapse. Cancer Res Ther Control. 1999;9:101-107. (Pubitemid 29408333)
15. Borowitz MJ, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood. 2008; 111(12):5477-5485.
16. Chen IM, Chakerian A, Combs D, Garner K, Viswanatha DS. Post-PCR multiplex fluorescent ligation detection assay and flow cytometry for rapid detection of gene-specific translocations in leukemia. Am J Clin Pathol. 2004;122(5):783- 793.
17. Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009;360(5):470-480.
18. Mullighan CG, Zhang J, Harvey RC, et al. JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2009; 106(23):9414-9418.
19. Zhang J, Finney RP, Rowe W, et al. Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB). Genome Res. 2007;17(7):1111-1117. (Pubitemid 47026358)
20. Zhang J, Wheeler DA, Yakub I, et al. SNPdetector: a software tool for sensitive and accurate SNP detection. PLoS Comput Biol. 2005;1(5): e53.
21. Harvey RC, Mullighan CG, Wang X, et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 2010; 116(23):4874-4884.
22. Kang H, Chen IM, Wilson CS, et al. Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood. 2010; 115(7):1394-1405.
23. Loudin MG, Wang J, Eastwood Leung HC, et al. Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles. Leukemia. 2011;25(10):1555-1563.
24. Rand V, Parker H, Russell LJ, et al. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia. Blood. 2011; 117(25):6848-6855.
25. Roberts KG, Morin RD, Zhang J, et al. Novel chromosomal rearrangements and sequence mutations in high-risk Ph-like acute lymphoblastic leukemia [abstract]. Blood (ASH Annual Meeting Abstracts). 2011;118:67a.